congressis 2018


Msc. Bioeng. Bogdan DIMITRIU

Certified Prosthetist and Orthotist

My Irak experience with bionic prosthesis technology.
Classical versus osseointegration prosthesis

Advances in prosthetic technology have been closely linked to armed conflict. Nowadays, high-end technology allows soldiers to be fitted with a prosthesis fast, accurately and with minimal resources. During this conference, our guest speaker, Msc. Bioeng. Dimitriu Bogdan, certified Prosthetist and Orthotist, Will talk about his experience in Iraq and discuss the two major techniques he used during his time there: the classical system MSS, which allows a patient to be fitted in maximum 1 hour, and  the Rheo knee, a bionic knee used exclusively for osseointegrated prosthesis. If you are interested in trauma surgery or emergency medicine and want to learn more about practising medicine under extreme pressure, Congressis 2018 is the place to be!

The microbiome - an old man, with a new hat

In the last years, the new concept, the microbiome, replaces former one, normal flora. Different highly sophisticated laboratory methods, as metagenomics – that answers the question: who the microorganisms of normal flora are, metatranscritomics – that answers the question: what bacteria from a population do at a time, metaproteomics and metabolomics – which helps us find out what they are doing, change our knowledge regarding our ecological barrier.

Microorganisms from normal flora (bacteria, viruses and fungi) and their genetic equipment work together in a large community: they support each other, they play a main role in pathogenesis of different diseases (asthma, diabetes, colorectal cancer, rheumatoid arthritis, autism, etc.). Future studies regarding the complex universe of microbiome, will help us find new diagnostic and treatment methods.

iancu final

Professor Luminița Smaranda IANCU, MD, PhD

Prorector assigned on post-graduate studies and Chief of Department of Microbiology at "Gr. T. Popa" University of Medicine and Pharmacy of Iași


Professor Lucian MIRON, MD, PhD

Vicepresident of the National Society of Medical Oncology in Romania, Head of Medical Oncology Clinic at the Regional Institute of Oncology of Iași and Chief of Department of Medical Oncology and Radiotherapy at "Gr. T. Popa" University of Medicine and Pharmacy of Iași

Triple negative breast cancer - a new entitity, new targeted agents and immunotherapy

Triple-negative breast cancers (TNBCs), defined by lack of expression of estrogen receptor, progesterone receptor and HER2, account for 12–17% of breast cancers. Nonetheless, TNBC has been shown to constitute a vastly heterogeneous disease encompassing a wide spectrum of entities with marked genetic, transcriptional, histological and clinical differences.

TNBC has an aggressive natural history, with an increased mortality rate during the first 5 years and typically, there is a high risk of early recurrence and this tends to occur within the first 4 years after diagnosis.

TNBC is a breast cancer subtype with only chemotherapy as the conventional treatment. Ongoing and future trials will define the role of immune checkpoint blockade in the treatment of TNBC. The hope is that immune checkpoint blocking antibodies will change the standard of care  for TNBC.

Hemophagocytic Lymphohistiocytosis - A Pediatric Diagnostic Challenge

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of pathologic immune activation characterized by clinical signs and symptoms of severe inflammation. It was described as both a familial disorder and as a sporadic one, in association with infections, malignancies, or rheumatologic disorders. 

Although HLH appears to be a disease of excessive immune activation, the ideal form of immune suppression/anti-inflammatory therapy remains unknown. A 4 months old infant HCH case admitted in Pediatric Hematology and Oncology Unit will be presented.

Ingrith Miron site

Professor Ingrith MIRON, MD, PhD

Head of Pediatrics Clinic at St. Mary Clinical Emergency Hospital for Children -Pediatric Hematology and Oncology Unit- and Chief of the Department of Pediatrics at “Gr. T. Popa” University of Medicine and Pharmacy, Iași